Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Goal Attainment Scaling in Down Syndrome-associated Alzheimer's Disease (DS-AD) Sub-study

NCT06484426 is registered in ClinicalTrials.gov with LuMind IDSC Foundation as lead sponsor.

NCT NCT06484426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06484426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Goal Attainment Scaling in Down Syndrome-associated Alzheimer's Disease (DS-AD) Sub-study
Lead sponsor
LuMind IDSC Foundation
Phase
Observational
Overall status
Completed
Start date
June 30, 2021
Completion date
February 29, 2024
Enrollment
46 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease in down syndrome